Philippines Technology News API

{
    "totalArticles": 176976,
    "articles": [
        {
            "id": "c6ee353373593eeb6cf86aa532b6f260",
            "title": "Shows Second Law Dynamics Of Infinite Quantum Systems With Maximal Entropy Rise",
            "description": "Researchers have demonstrated a refined second law of thermodynamics, proving that isolated spin systems invariably evolve towards maximum mean entropy, evidenced by analysis of both predictable and chaotic one-dimensional models like the exponential and Dyson systems.",
            "content": "Researchers investigating the fundamental link between quantum dynamics and the second law of thermodynamics present compelling new evidence supporting a deterministic interpretation of entropy increase. Walter F. Wreszinski from the Instituto de Fis... [6036 chars]",
            "url": "https://quantumzeitgeist.com/quantum-systems-shows-second-law-dynamics-infinite/",
            "image": "https://quantumzeitgeist.com/wp-content/uploads/Image_fx-64-20.jpg",
            "publishedAt": "2026-02-04T19:36:10Z",
            "lang": "en",
            "source": {
                "id": "57e0972312d283bae70e31e5b557783c",
                "name": "Quantum Zeitgeist",
                "url": "https://quantumzeitgeist.com"
            }
        },
        {
            "id": "536ddb2ceb8562e3f03c07d9df79fea6",
            "title": "Boxing game Undisputed lands on PS Plus for February 2026",
            "description": "PS Plus subscribers can play as Canelo Alvarez, Muhammad Ali, Claressa Shields and more in Undisputed.",
            "content": "If you miss the glory days of Fight Night and own a PS5, you're in luck -- you can now download Undisputed as part of your PS Plus subscription.\nWith a roster of over 70 licensed fighters -- from Tyson Fury to Eddie Hall -- Undisputed is the best pla... [991 chars]",
            "url": "https://www.espn.ph/gaming/story/_/id/47825066/undisputed-boxing-ps-plus",
            "image": "https://a3.espncdn.com/combiner/i?img=%2Fphoto%2F2026%2F0204%2Fr1610271_799x799_1%2D1.jpg",
            "publishedAt": "2026-02-04T16:49:59Z",
            "lang": "en",
            "source": {
                "id": "a38b4683030b8963222bbd436bbe8ed5",
                "name": "ESPN Philippines",
                "url": "https://www.espn.ph"
            }
        },
        {
            "id": "32c72c38760d1a6db3677f0f828d7060",
            "title": "Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer",
            "description": "DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDAClinical entry validates condensate modulator discovery platform and its potential to address historically intractable targets through a novel mechanism BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics, Inc., a clinical-stage biotechnology company pioneering condensate-modulating therapeutics, today announced that the first patient has been dosed in a Phase 1a/2a clinical trial evaluating its lead beta-catenin program in patients with advanced solid tumors, with a focus on gastric cancer.",
            "content": "DPTX3186, a first-in-class beta-catenin condensate modulator, received Orphan Drug Designation and Fast Track Designation from FDA\nClinical entry validates condensate modulator discovery platform and its potential to address historically intractable ... [3720 chars]",
            "url": "https://www.manilatimes.net/2026/02/04/tmt-newswire/globenewswire/dewpoint-therapeutics-doses-first-patient-in-phase-1a2a-trial-dptx3186-for-the-treatment-of-advanced-solid-tumors-focused-on-gastric-cancer/2271829",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/02/04/925337.png",
            "publishedAt": "2026-02-04T15:05:01Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}